MEDICUS PHARMA LTD. Net Income (Loss) Available to Common Stockholders, Diluted
MEDICUS PHARMA LTD. (MDCX) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$6.18 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2025-08-11
- MEDICUS PHARMA LTD. net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was -$6.18M.
- MEDICUS PHARMA LTD. net income (loss) available to common stockholders, diluted for the quarter ending 2025-03-31 was -$5.10M.
- MEDICUS PHARMA LTD. net income (loss) available to common stockholders, diluted for the quarter ending 2024-06-30 was -$3.63M.
- MEDICUS PHARMA LTD. net income (loss) available to common stockholders, diluted for the quarter ending 2024-03-31 was -$1.71M.
- MEDICUS PHARMA LTD. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$11.16M.
- MEDICUS PHARMA LTD. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$5.31M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|
| 2025-06-30 | -$6.18M 10-Q · filed 2025-08-11 | -$11.28M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | -$5.10M 10-Q · filed 2025-05-12 | ||
| 2024-12-31 | -$11.16M 10-K · filed 2025-03-28 | ||
| 2024-06-30 | -$3.63M 10-Q · filed 2025-08-11 | -$5.34M 10-Q · filed 2025-08-11 | |
| 2024-03-31 | -$1.71M 10-Q · filed 2025-05-12 | ||
| 2023-12-31 | -$5.31M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |